159 related articles for article (PubMed ID: 2143553)
1. Drug therapy of sleep-related hypoxaemia.
Weitzenblum E; Apprill M; Oswald M; Kurtz D
Lung; 1990; 168 Suppl():948-54. PubMed ID: 2143553
[TBL] [Abstract][Full Text] [Related]
2. Comparison of almitrine bismesylate and medroxyprogesterone acetate on oxygenation during wakefulness and sleep in patients with chronic obstructive lung disease.
Daskalopoulou E; Patakas D; Tsara V; Zoglopitis F; Maniki E
Thorax; 1990 Sep; 45(9):666-9. PubMed ID: 2145654
[TBL] [Abstract][Full Text] [Related]
3. Almitrine effect on nocturnal hypoxaemia in patients with chronic obstructive pulmonary disease (COPD).
Daskalopoulou E; Patakas D; Tsara V; Kazis A; Maniki E; Zoglopitis F
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():185s-190s. PubMed ID: 3690030
[TBL] [Abstract][Full Text] [Related]
4. One year treatment with almitrine improves hypoxaemia but does not increase pulmonary artery pressure in COPD patients.
Weitzenblum E; Schrijen F; Apprill M; Prefaut C; Yernault JC
Eur Respir J; 1991 Nov; 4(10):1215-22. PubMed ID: 1804669
[TBL] [Abstract][Full Text] [Related]
5. The effect of long-term almitrine therapy on sleep hypoxaemia in patients with chronic airways obstruction.
Racineux JL; Meslier N; Hubert P
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():183s-184s. PubMed ID: 3690029
[TBL] [Abstract][Full Text] [Related]
6. Sleep in chronic obstructive lung disease.
Flenley DC
Clin Chest Med; 1985 Dec; 6(4):651-61. PubMed ID: 2935359
[TBL] [Abstract][Full Text] [Related]
7. Sleep and chronic obstructive pulmonary disease.
Weitzenblum E; Chaouat A
Sleep Med Rev; 2004 Aug; 8(4):281-94. PubMed ID: 15233956
[TBL] [Abstract][Full Text] [Related]
8. Association of oral almitrine and medroxyprogesterone acetate: effect on arterial blood gases in chronic obstructive pulmonary disease.
Pinet C; Tessonnier F; Ravel T; Orehek J
Respir Med; 2001 Jul; 95(7):602-5. PubMed ID: 11453318
[TBL] [Abstract][Full Text] [Related]
9. Sleep-related hypoxaemia in chronic obstructive pulmonary disease: causes, consequences and treatment.
Weitzenblum E; Chaouat A; Charpentier C; Ehrhart M; Kessler R; Schinkewitch P; Krieger J
Respiration; 1997; 64(3):187-93. PubMed ID: 9154669
[TBL] [Abstract][Full Text] [Related]
10. [Sleep and COPD].
Weitzenblum E; Chaouat A; Charpentier C; Krieger J
Rev Prat; 1995 May; 45(10):1257-60. PubMed ID: 7659971
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of almitrine bismesylate on oxygenation during wakefulness and sleep in chronic obstructive pulmonary disease.
Gothe B; Cherniack NS; Bachand RT; Szalkowski MB; Bianco KA
Am J Med; 1988 Mar; 84(3 Pt 1):436-44. PubMed ID: 2894764
[TBL] [Abstract][Full Text] [Related]
12. The hypoxaemia in chronic obstructive pulmonary disease (COPD) and its management.
Voisin C
Wiad Lek; 1998; 51(1-2):11-4. PubMed ID: 9608825
[TBL] [Abstract][Full Text] [Related]
13. Sleep-related O2 desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia.
Chaouat A; Weitzenblum E; Kessler R; Charpentier C; Ehrhart M; Levi-Valensi P; Zielinski J; Delaunois L; Cornudella R; Moutinho dos Santos J
Eur Respir J; 1997 Aug; 10(8):1730-5. PubMed ID: 9272911
[TBL] [Abstract][Full Text] [Related]
14. Sleep quality, carbon dioxide responsiveness and hypoxaemic patterns in nocturnal hypoxaemia due to chronic obstructive pulmonary disease (COPD) without daytime hypoxaemia.
Sandek K; Andersson T; Bratel T; Hellström G; Lagerstrand L
Respir Med; 1999 Feb; 93(2):79-87. PubMed ID: 10464857
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of almitrine bismesylate in COPD patients with chronic hypoxaemia.
Sans-Torres J; Domingo C; Morón A; Rué M; Marín A
Respir Med; 2003 Jun; 97(6):599-605. PubMed ID: 12814142
[TBL] [Abstract][Full Text] [Related]
16. [Pulmonary artery hypertension and nocturnal hypoxemia in chronic obstructive bronchopneumopathy].
Apprill M; Weitzenblum E
Rev Mal Respir; 1991; 8(1):13-27. PubMed ID: 2034851
[TBL] [Abstract][Full Text] [Related]
17. [An improvement in the hypoxemia after almitrine treatment in patients with chronic obstructive pulmonary diseases].
Marcos Sánchez F; Celdrán Gil J; Santurino Martín JA; Hernández Lanchas C; Durán Pérez-Navarro A
Aten Primaria; 1993 Nov; 12(9):628-9. PubMed ID: 8298000
[No Abstract] [Full Text] [Related]
18. Sleep related O2 desaturation in COPD patients with normoxaemia and mild hypoxyaemia.
Resta O; Foschino-Barbaro MP; Talamo S; Nocerino MC; Stefano A; Corvaglia G
Boll Soc Ital Biol Sper; 1998; 74(9-10):91-8. PubMed ID: 10904558
[TBL] [Abstract][Full Text] [Related]
19. Selection of patients for long-term oxygen therapy (LTO).
Levi-Valensi P; Aubry P; Rida Z; Rose D; Ndarurinze S; Jounieaux V
Eur Respir J Suppl; 1989 Jul; 7():624s-629s. PubMed ID: 2508650
[TBL] [Abstract][Full Text] [Related]
20. Inhaled nitric oxide, almitrine infusion, or their coadministration as a treatment of severe hypoxemic focal lung lesions.
Paven D; Muret J; Beloucif S; Gatecel C; Kermarrec N; Guinard N; Mateo J
Anesthesiology; 1998 Nov; 89(5):1157-65. PubMed ID: 9822004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
